{"address1": "12265 El Camino Real", "address2": "Suite 350", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858 727 1040", "fax": "858 614 7007", "website": "https://www.connectbiopharm.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. The company is building a pipeline of small molecules and antibodies using functional T cell assays to screen and discover potent product candidates against validated immune targets. Its lead product candidate is rademikibart (formerly CBP-201), an antibody designed to target interleukin-4 receptor alpha, which is a validated target for the treatment of inflammatory diseases such as atopic dermatitis and asthma, currently under Phase 3 studies; and icanbelimod (formerly CBP-307), an oral small molecule Sphingosine 1-Phosphate Receptor 1 modulator, currently under Phase 2 clinical for the treatment of ulcerative colitis and Crohn's disease. The company was founded in 2012 and is based in San Diego, California.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Barry D. Quart Pharm.D.", "age": 67, "title": "CEO & Director", "yearBorn": 1957, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David L. Szekeres J.D.", "age": 50, "title": "President", "yearBorn": 1974, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Peraza CPA", "age": 47, "title": "Vice President of Finance", "yearBorn": 1977, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jeff  Cohn J.D.", "title": "General Counsel & Corporate Secretary", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lei  Sun Ph.D.", "age": 60, "title": "VP of Biologics & Head of CMC", "yearBorn": 1964, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul  Collazo Ph.D.", "title": "VP & Global Head of Medical Affairs", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Srikanth  Pendyala M.D.", "title": "Senior Vice President of Clinical Development(Consultant)", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kimberly J. Manhard", "age": 64, "title": "Chief Development Officer", "yearBorn": 1960, "exercisedValue": 0, "unexercisedValue": 0}], "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.55, "open": 0.63, "dayLow": 0.55, "dayHigh": 0.7718, "regularMarketPreviousClose": 0.55, "regularMarketOpen": 0.63, "regularMarketDayLow": 0.55, "regularMarketDayHigh": 0.7718, "payoutRatio": 0.0, "forwardPE": -2.861, "volume": 683969, "regularMarketVolume": 683969, "averageVolume": 31916, "averageVolume10days": 103110, "averageDailyVolume10Day": 103110, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 31616338, "fiftyTwoWeekLow": 0.55, "fiftyTwoWeekHigh": 2.308, "priceToSalesTrailing12Months": 1.2144716, "fiftyDayAverage": 0.88038, "twoHundredDayAverage": 1.11985, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -61859184, "profitMargins": -0.60030997, "floatShares": 14816983, "sharesOutstanding": 55254000, "sharesShort": 10250, "sharesShortPriorMonth": 29790, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0002, "heldPercentInsiders": 0.41089, "heldPercentInstitutions": 0.44777, "shortRatio": 0.5, "shortPercentOfFloat": 0.00029999999, "impliedSharesOutstanding": 62621200, "bookValue": 1.665, "priceToBook": 0.34366366, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -15628000, "trailingEps": -0.39, "forwardEps": -0.2, "enterpriseToRevenue": -2.376, "enterpriseToEbitda": 2.839, "52WeekChange": -0.7314554, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 0.5722, "targetHighPrice": 8.0, "targetLowPrice": 6.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 2, "totalCash": 93708000, "totalCashPerShare": 1.693, "ebitda": -21792000, "totalDebt": 178000, "quickRatio": 11.167, "currentRatio": 11.458, "totalRevenue": 26033000, "debtToEquity": 0.193, "revenuePerShare": 0.472, "returnOnAssets": -0.12354, "returnOnEquity": -0.16177, "grossProfits": 26033000, "freeCashflow": -30779500, "operatingCashflow": -23612000, "grossMargins": 1.0, "ebitdaMargins": -0.83709, "operatingMargins": -14.81168, "financialCurrency": "USD", "symbol": "CNTB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Connect Biopharma Holdings Limi", "corporateActions": [], "preMarketTime": 1743593743, "regularMarketTime": 1743537601, "exchange": "NGM", "messageBoardId": "finmb_706016439", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyDayAverageChange": -0.30817997, "fiftyDayAverageChangePercent": -0.35005337, "twoHundredDayAverageChange": -0.54765004, "twoHundredDayAverageChangePercent": -0.48903874, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-03-19", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1616160600000, "preMarketChange": -0.0022000074, "preMarketChangePercent": -0.38448226, "preMarketPrice": 0.57, "regularMarketChange": 0.022199988, "regularMarketDayRange": "0.55 - 0.7718", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 31916, "fiftyTwoWeekLowChange": 0.022199988, "fiftyTwoWeekLowChangePercent": 0.040363614, "fiftyTwoWeekRange": "0.55 - 2.308", "fiftyTwoWeekHighChange": -1.7358, "fiftyTwoWeekHighChangePercent": -0.7520797, "fiftyTwoWeekChangePercent": -73.14554, "earningsTimestamp": 1743426000, "earningsTimestampStart": 1743426000, "earningsTimestampEnd": 1743426000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.39, "epsForward": -0.2, "epsCurrentYear": -1.12, "priceEpsCurrentYear": -0.51089287, "longName": "Connect Biopharma Holdings Limited", "regularMarketChangePercent": 4.036361, "regularMarketPrice": 0.5722, "displayName": "Connect Biopharma", "trailingPegRatio": null}